Statistics

Total Visits

Views
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain3

File Visits

Downloads

Select a period of time:

Number of views in the range

Views
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain3

Number of downloads in the range

Downloads

Views

Views
April 20250
May 20250
June 20250
July 20250
August 20250
September 20253
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil2
Argentina1
 

Top cities views

Views
Laranjal Paulista1
Nova Londrina1
Tunuyán1